Tour de Bleu, a 160-kilometre private cycling event hosted by the Peter Gilgan Foundation and Mattamy Homes, has raised $3.66 million to support a bold new national strategy for the treatment and prevention of women’s cancers being developed at Women’s College Hospital (WCH).
“The leadership, vision and profound generosity of Peter Gilgan and the incredible Tour de Bleu riders is unparalleled,” states Katherine Hay, president and CEO of Women’s College Hospital Foundation. “These are individuals who are determined in their commitment to give every woman, every chance to survive cancer.”
The funds raised by Tour de Bleu will support critical work being done within The Peter Gilgan Centre for Women’s Cancers at Women’s College Hospital, launching a national strategy designed to transform care for women’s cancers on a national scale in collaboration with the Canadian Cancer Society.
By drawing together WCH’s excellence in research, clinical care, innovation and education and then leveraging that knowledge across the country, the vision and long-term goal of the Centre, shared by all the riders of Tour de Bleu, is to ensure that every Canadian woman receives access to the highest standard of care in the prevention, diagnosis, treatment and survivorship of cancer – no matter where she lives.
“As a father and a grandfather, it’s extremely important to me to ensure my children, their children and all future generations of Canadians in communities across the country have access to the very best healthcare that can be delivered – and this is what we can make happen,” says Peter Gilgan, founder of Mattamy Homes and one of Canada’s most influential philanthropists. “What Women’s College is doing to create equitable access to their world-leading work in the areas of cancer research, education and models of care is invaluable and it is something our riders, our sponsors and my family are very proud to support.”
Last year, Tour de Bleu raised $3.25 million for Women’s College Hospital – then a record breaking amount – to support research within the Hereditary Cancers Unit and the Women’s College Institute for Health System Solutions and Virtual care. It was the single-largest gift ever made by a group of private donors in support of WCH’s global leadership in the prevention, screening and treatment of hereditary breast and ovarian cancer, and it was the largest amount ever raised through Tour de Bleu since its launch in 2005.
Leveraging the incredible success of last year’s gift in support of hereditary cancer research, Tour de Bleu riders wanted to extend their support this year to reach as many women and families as possible by advancing WCH’s work across all aspects of care for women’s cancers.